23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million



Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *